Standpoint Research将以色列制药商Teva Pharmaceuticals (TEVA)的股票评级从“买进”下调为“持有”。

(via:sina)

标签：以色列,股票,TevaStandpoint,Teva,TEVA,Standpoint,Research,Pharmaceuticals